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Abstract
Background: In Great Britain (GB), data collected on pesticide associated illness focuses on acute
episodes such as poisonings caused by misuse or abuse. This study aimed to investigate the extent
and nature of pesticide-related illness presented and diagnosed in Primary Care and the feasibility
of establishing a routine monitoring system.
Methods: A checklist, completed by General Practitioners (GP) for all patients aged 18+ who
attended surgery sessions, identified patients to be interviewed in detail on exposures and events
that occurred in the week before their symptoms appeared.
Results: The study covered 59320 patients in 43 practices across GB and 1335 detailed interviews.
The annual incidence of illness reported to GPs because of concern about pesticide exposure was
estimated to be 0.04%, potentially 88400 consultations annually, approximately 1700 per week. The
annual incidence of consultations where symptoms were diagnosed by GPs as likely to be related
to pesticide exposure was 0.003%, an annual estimate of 6630 consultations i.e. about 128 per
week. 41% of interviewees reported using at least one pesticide at home in the week before
symptoms occurred. The risk of having symptoms possibly related to pesticide exposure compared
to unlikely was associated with home use of pesticides after adjusting for age, gender and
occupational pesticide exposure (OR = 1.88, 95% CI 1.51 – 2.35).
Conclusion: GP practices were diverse and well distributed throughout GB with similar symptom
consulting patterns as in the Primary Care within the UK. Methods used in this study would not be
feasible for a routine surveillance system for pesticide related illness. Incorporation of
environmental health into Primary Care education and practice is needed.
Background
Pesticides, pesticide products and related chemicals have
been found to have a wide range of health effects. They
include: mutagenic substances, carcinogens or probable
carcinogens, endocrine disrupters, reproductive toxic sub-
stances and neurotoxic substances [1,2]. The effect of low-
level, long-term exposure has been of recent concern, with
the organophosphate pesticides as a group receiving a
great deal of medical research interest, particularly with
regard to their potential effects on farmers using sheep
dips [2-4]. Although pesticides have undoubted acute
health effects, these usually occur as a result of accidental
Published: 6 July 2009
BMC Public Health 2009, 9:219 doi:10.1186/1471-2458-9-219
Received: 28 January 2009
Accepted: 6 July 2009
This article is available from: http://www.biomedcentral.com/1471-2458/9/219
© 2009 Rushton and Mann; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Public Health 2009, 9:219 http://www.biomedcentral.com/1471-2458/9/219
Page 2 of 11
(page number not for citation purposes)
or deliberate misuse. In the UK, information on acute
events can be obtained, for example, from the NHS Hos-
pital Episode Statistics [5]. Much less is known about the
incidence of ill-health due to low-levels of pesticide expo-
sure and there are currently no surveillance schemes in
Primary Care in Great Britain that identify an illness as
possibly due to pesticide exposure, whether occupational
or environmental.
The aim of this study was to fill this gap in knowledge and
in particular to: estimate the annual national incidence
and prevalence of pesticide-related illness presented to
and diagnosed by General Practitioners (GP); investigate
associations between symptoms and possible pesticide
exposure, evaluate the feasibility and practicalities of set-
ting up permanent arrangements to collect data on pesti-
cide related illness in Primary Care. As few patients (92:
7% of interviewees) reported occupational use of pesti-
cides, this paper focuses on results related to home and
environmental pesticide exposure, a fuller technical
report is available elsewhere [6].
There are several challenges in surveillance of pesticide
related illness in general practice including the large
number of symptoms (often rather vague) that could
potentially result from low-level exposure to pesticides
and the lack of readily available sensitive, specific and
interpretable biological tests to confirm exposure. Most
GPs, presented with a patient reporting such symptoms in
the absence of reported exposure to pesticides, do not rou-
tinely consider the possibility of pesticide exposure. Any
surveillance system must therefore encourage the GP to
consider further a possible relationship but without over-
prompting. The project thus focussed on patients who
consulted to report recent pesticide exposure, with or
without current symptoms, and on patients who pre-
sented with symptoms that were 'unusual' for them i.e. a
new occurrence and not a chronic recurring problem and
that the GP considered could potentially be related to a
(possible) recent pesticide exposure. Although it was
thought that acute severe illness related to high exposure
was likely to lead to presentation and treatment in sec-
ondary care rather than primary care it was also thought
important to capture any acute symptoms.
Methods
The study was carried out between 2003 and 2006 in gen-
eral practices from the UK General Practice Research
Framework, an organisation of almost 1100 general prac-
tices throughout the UK involved in epidemiological and
health service research [7]. The GPRF network covers over
9% of UK practices, giving access to 12% of the popula-
tion, with sufficient number of all types and in all areas to
provide representative samples of the UK practices with
regard to demographic characteristics and agricultural
practices. Of particular relevance to this project is that
14% of the practices are in areas classified by the Office of
National Statistics as remote rural and 17% are in mixed
urban/rural areas. Information about the study and an
invitation to participate was sent to all GPs on the GPRF
database. Each participating GP completed a one page
screening checklist for all patients aged 18 years or over
consulting during a surgery session. Our pilot study indi-
cated that GPs would be unwilling to use the screening
checklist at all surgery sessions. They were therefore
requested to do this for at least 2 sessions per week during
a year of data collection. The practice research nurse
organised a continuous flow of both checklists and inter-
views throughout the data collection period assuring that
the consultation sessions occurred on different days and
in both mornings and afternoons to ensure representation
of patient consulting patterns (e.g. not always on Monday
mornings or Friday afternoons when more acute or urgent
consultations might take place).
An information pack was provided for GPs on pesticide-
related illnesses with instructions on how to complete the
checklist. The research nurses attended training days and,
during the project, back-up training or additional support
was provided by GPRF regional training nurses who were
also responsible for quality control during the study
ensuring standardisation and checking that the practice
was fulfilling all the requirements of research governance.
GPs were asked to carry out their 'normal' consulting prac-
tice and to complete the checklists at the end of the con-
sultation.
The checklist was used to identify patients who attended,
with or without reporting symptoms, because of their
concern about exposure to pesticides and those patients
consulting with symptoms that were unusual for them.
On each checklist GPs were asked to record their opinion
of whether the patient's symptoms were likely, possibly,
unlikely to be or definitely not related to pesticide expo-
sure. A computer algorithm selected patients who were
eligible for an invitation to an in-depth interview with the
research nurse if:
￿ They consulted because of their concern about expo-
sure to pesticides regardless of the opinion of the GP
about potential relation to pesticide exposure.
￿ They had serious acute symptoms such as blurring of
vision, vertigo, respiratory compromise that were not
definitively attributed by the GP to a cause other than
pesticides exposure
￿ They had newly occurring flu type, respiratory, gas-
tro-intestinal, skin, eye or neurological symptoms,
which were unusual for the patient and were notBMC Public Health 2009, 9:219 http://www.biomedcentral.com/1471-2458/9/219
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definitively attributed by the GP to a cause other than
pesticides exposure
￿ They had the above symptoms which were not unu-
sual, i.e. recurring symptoms, for the patient but
which the GP thought were likely or possibly related
to pesticide exposure
Initially ethical approval was only given to approach eligi-
ble patients about an interview by a single letter without a
reminder. As about 40% of the eligible patients in the
pilot study did not respond to the invitation to attend for
interview, the Chairman of the Ethics Committee was
approached and approval was obtained for sending
reminder invitation letters to non-responders. Later per-
mission was also obtained to carry out the interview over
the telephone although this method was seldom preferred
by patients.
The computer-based interview questionnaire consisted of
sections on:
1. Occupational exposure, including applying and
mixing pesticides during work, formulations, fre-
quency and duration of potential exposure, sub-
stance(s) including chemical and/or brand name and
use of personal protective equipment.
2. Amateur use at home and in the garden including
the use and mixing of pesticides, occurrences of pro-
fessional pest control in the home and the storage and
disposal of pesticides at home.
3. Hobbies and leisure during which exposure to haz-
ardous materials or pesticides might have occurred.
4. Other suspected exposure to pesticides, including
incidents such as accidental exposures from spray drift
and incidents occurring in public places and near
farmland.
5. Demographic, medical and miscellaneous informa-
tion
All the questions focussed on exposures and events that
occurred in the week before the symptoms appeared.
Patients were asked about the numbers of days' use of pes-
ticides and whether this was more use than usual. Infor-
mation on use of other substances in the home that
potentially might lead to similar symptoms as those
expected from pesticides (e.g. detergents, solvents, paints,
etc.) and whether they had been used more frequently, in
a larger quantity or with a change of brand was also col-
lected.
Before the main study, a pre-pilot phase was carried out in
Northern Ireland to test the feasibility of the GP adminis-
tered checklist followed by a pilot study in 9 practices in
England and Wales to pilot both the use of the checklist
and the interview questionnaire (see additional file 1).
Some changes were made for the main study to improve
accuracy of responses, to ensure questions could not be
omitted and to improve clarity.
To ensure that duplicate interviews did not take place
nurses were instructed not to invite a patient more than
once if the patient had consulted more than once within
a short period of time for the same illness and more than
one checklist had been completed. However, a consulta-
tion could be considered as a separate episode if there was
a gap of at least two weeks between consultations and it
was clearly for a new problem.
Ethical approval was obtained through the UK Multi-cen-
tre Research Ethics Committees (Wales) and research gov-
ernance approval was obtained from all the relevant
Primary Care Organisations.
Statistical analyses were carried out using statistical soft-
ware Stata version 9.2. Estimations of annual incidence
proportion (cumulative incidence) and prevalence (pro-
portion) of pesticide-related illness presented to GPs used
the total number of patients screened as denominator,
while the estimations of incidence and prevalence of pos-
sibly or likely pesticide-related illness diagnosed by GPs,
without the patients specifically mentioning exposure,
excluded the number of patients who reported exposure
from the denominator. Annual incidence estimations
included only patients with newly occurring symptoms in
the nominators; annual prevalence estimations also
included those who presented with recurring symptoms.
Ninety five percent confidence intervals for incidence and
prevalence were estimated using the normal approxima-
tion or the exact method if the numbers were small.
Statistical methods included descriptive analyses together
with univariable and multivariable logistic regressions to
assess the association between risk factors and potential
pesticide-related illness using robust standard error esti-
mation to take account of clustering of patients within GP
practices.
Results
Participating practices
157 GPs and 7 nurse practitioners participated from 43
practices between November 2004 and July 2006 (not
necessarily all GPs in a participating practice). Six prac-
tices withdrew within 4 months or less. Reasons given for
withdrawal included illness of the research nurse or GP,
changes of GPs resulting in replacements being unwillingBMC Public Health 2009, 9:219 http://www.biomedcentral.com/1471-2458/9/219
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to participate and heavy practice workloads. The majority
carried out the study for well over 6 months giving an
average of 52.6 weeks. The number of checklists com-
pleted per session was generally quite consistent between
practices, varying between 6 and 14 giving an average of
11 per session.
The practices were spread throughout GB; industrial areas
(5), cities or urban areas including outer London and met-
ropolitan districts (13), mixed urban and rural areas
including new towns and coastal resorts (12), rural areas
(13) (Figure 1). The number of partners in the practices
ranged from 1 to 8 or more, with practice sizes ranging
from about 4000 patients to over 13000.
Eligibility for and response to interview invitation
59320 checklists (male patients 40.4%) were completed
during 5446 GP surgery sessions. Nearly 25% (14490) of
patients were asymptomatic and consulting the GP for
other reasons and one patient, though asymptomatic,
consulted the GP because of exposure to pesticides. 4741
(8%) patients were identified as eligible for invitation for
interview, all of whom were received an invitation. 1335
patients (28.2% of those eligible and 49.8% of those who
did not refuse) completed the interview, 2060 (43.5%)
refused to be interviewed and 1346 (28.4%) had not
replied by the end of the study. The distributions of symp-
toms were similar in all three groups regardless whether
the patients agreed, refused to be interviewed or did not
respond. On average, non-responders and those who
refused to be interviewed were slightly younger than those
who were not eligible and those who completed the inter-
view (mean ages 46.3, 51.1, 54.2, 56.7 years respectively).
Similar proportions of men and women were eligible for
an interview (8.7%, 7.5% respectively). Of those who
were eligible proportions who refused to be interviewed
were similar for men (44%) and women (43%) as were
proportions who did not respond (29.1% men, 27.8%
women).
Incidence and prevalence of symptoms related to pesticide 
exposure
Forty two people consulted because of their concern
about exposure to pesticides. The GP thought the symp-
toms were likely to be related to exposure to pesticides for
13 of these patients and also for a further 7 patients who
did not report exposure (Table 1).
GPs also thought that 1599 patients (2.7% overall) had
symptoms that were possibly related to pesticide exposure
(33.7% of all eligible patients). 18557 patients (31.3%
overall) were thought by the GP to have symptoms that
were unlikely to be related to pesticide exposure, 3120 of
these patients were eligible for in-depth interview (65.8%
of all eligible patients).
As the average number of weeks for which the study was
carried out was approximately a year, no weighting was
carried out for the prevalence and incidence estimation.
The denominator for estimating the annual incidence and
prevalence for pesticide-related illness presented to GPs
was thus the total number of patients screened (59320)
and for pesticide-related illness diagnosed by GPs it was
59278 i.e. excluding the 42 patients who reported expo-
sure to pesticides (Table 1).
The annual prevalence of consultations because of con-
cern by the patient about pesticide exposure is estimated
to be 0.07% (42/59320) (95% CI 0.05%, 0.09%) and the
estimate of the annual incidence (i.e. new cases) is 0.04%
(24/59320) (95% CI 0.02%, 0.06%) (Table 1). For people
who did not consult because of concern about exposure to
pesticides, the estimate of the annual prevalence of con-
sultations for which the GP thought the symptoms were
likely to be related to pesticide exposure is extremely
small, 0.01% (7/59278) (95% exact CI 0.004%, 0.02%),
with an estimate of those with symptoms thought by the
GP to be possibly related to pesticide exposure being 2.7%
(1581/59278) (95% CI 2.5%, 2.8%). The annual inci-
dence of consultations for which the GP though symp-
toms were likely to be related to pesticide exposure is
0.003% (2/59278) (95% exact CI 0%, 0.01%) and the
annual estimate of those with symptoms thought by GP to
be possibly related to pesticide exposure is 1.6% (972/
59278) (95% CI 1.5%, 1.7%) respectively.
In 2001, GPs in the UK carried out about 221 million con-
sultations (patients aged 16 years or more), [8]. Although
our study was based on people aged 18 years or more in
GB (excluding Northern Ireland) the estimate of an
annual incidence of 0.04% for consultations made by
patients because of concern about pesticides translates to
an annual estimate of 88400 consultations i.e. approxi-
mately 1700 per week for people aged 16 years or over.
Similarly the annual incidence of 0.003% for those
patients not consulting because of concern about pesti-
cide exposure but for whom the GP thought their symp-
toms were likely to be related to pesticide exposure
translates to an annual estimate of 6630 consultations i.e.
about 128 per week for people aged 16 years or over.
Home use of pesticides
547 (41%) interviewees reported using at least one pesti-
cide in the home environment in the week before symp-
toms occurred (273 patients, 20% used 2 or more). The
most frequently used pest control chemicals used at home
in the week before symptoms occurred were slug and snail
pellets and weed killer (table 2). For most of the chemicals
in table 2 over half the patients reported that they had
used it more than usual during that week. Almost a third
of the pesticides were applied with an aerosol or spray,BMC Public Health 2009, 9:219 http://www.biomedcentral.com/1471-2458/9/219
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25% as liquid and 21% as pellets or granules. 65.4%
(358) of home pesticide users had used no personal pro-
tective equipment when applying the chemicals, although
284 patients (51.9%)) reported that their arms and legs
were covered.
In deciding on the quantity of pesticide to use 103
patients (44.6%) reported that they followed the label
exactly, 103 patients (18.8%) used it as guidance, and 210
patients (38%) used their previous experience. The major-
ity of pesticides stored at home were kept in the kitchen
(15.7%) and/or in the garage or shed (63.3%).
61.5% of interviewees reported that they never disposed
of pesticides and 25.5% disposed of them in the house-
hold rubbish bin. Relatively few reported that they used a
chemical waste disposal site (2.2%) or other waste dis-
posal site (7.1%).
The proportions of patients presenting with eye, skin, gas-
trointestinal or respiratory symptoms were almost identi-
cal for patients who used or did not use pesticides. A
slightly higher proportion of the users had neurological
and a slightly lower proportion of them had multiple
symptoms (data not shown). However, almost twice as
many of non users visited their GP because of flu symp-
toms compared with users.
The number of patients who reported some sort of change
in use (more frequent use, change of brand, and/or larger
quantity) of hazardous materials in the home other than
pesticides was small. However, there was a slight tendency
based on small numbers for an increased proportion of
respiratory symptoms among patients who also used pes-
ticides compared with those who did not use pesticides.
A follow-up questionnaire was sent to GPs after the study
to investigate the criteria they used to categorize the symp-
toms of each presenting patient as possibly or likely to be
related to pesticide exposure. It appeared that the decision
by the GPs to use the category 'possibly related to pesti-
cide exposure' was more often based on a discussion of
both symptoms and activities (48% versus 41% of GPs),
but less often based on pesticide alone (1% versus 19% of
GPs) or included a discussion on specific pesticide expo-
sure (10% versus 27% of GPs) compared to the decision
to use the category 'likely'. Eligibility for invitation for an
interview could thus have been biased by consideration of
exposures, since those patients categorized by the GP as
likely were automatically invited for an interview. For this
reason logistic regression analysis was carried out exclud-
ing the likely group and those who consulted because of
concern about pesticide exposure, thus comparing the risk
of patients being categorised by their GP as having symp-
toms possibly related to pesticide exposure with those
classified as unlikely to have symptoms related to pesti-
cide exposure (1316 patients). Home use of pesticides
and the change in use of several commonly used sub-
stances at home in the week before symptoms occurred
showed statistically significant increased risk (Table 3 uni-
variable results, based on 1316 patients categorised by the
GP as having symptoms possibly related to pesticides).
In multivariable models that included occupational and
home use of pesticides, age and gender, and change in use
of each of the 12 commonly used substances in Table 3 in
Table 1: General Practitioner's opinion on likelihood of symptoms being related to pesticides
Reason for Consultation New or Recurring Symptoms GP's opinion on likelihood of symptoms being pesticide-related
Likely Possible Unlikely Definitely not Total
Because of concern about 
pesticide exposure
Asymptomatic 000 0 1
Recurring 246 1 1 3
Newly occurring 10 11 3 0 24
Not known 130 0 4
Total 13 18 9 1 42
Pesticide exposure not 
mentioned by patient
Asymptomatic 000 0 1 4 4 9 0
Recurring 5 528 13451 20207 34191
Newly occurring 2 972 4165 4020 9159
Not known 0 81 932 425 1438
Total 7 1581 18548 24652 59278
Overall total 20 1599 18557 24653 59320BMC Public Health 2009, 9:219 http://www.biomedcentral.com/1471-2458/9/219
Page 7 of 11
(page number not for citation purposes)
turn, none of the 12 substances altered the odds ratios for
occupational or home use of pesticides substantially (ORs
for occupational pesticide use ranged from 0.97 to 1.01
and ORs for home use of pesticides ranged from 1.83 to
1.88). These variables do not appear therefore to be con-
founding the effect of occupational and home pesticide
use. The risk associated with changed use of paint, toilet-
ries and furniture renovator remained significantly raised
in these analyses, although based on small numbers.
The results of a multivariable model including occupa-
tional and home use of pesticides, age as a continuous var-
iable and gender are given in Table 4 and show a
statistically significant increased risk for being categorised
as having possible pesticide related symptoms if the pesti-
cide was used at home (OR = 1.88, 95% CI 1.51 – 2.35)
(Table 4).
Discussion
The results from this study suggest that the incidence and
prevalence of ill health presenting to and diagnosed in
Primary Care as related to pesticides in GB are small but
that this could result in considerable numbers of consul-
tations. There are no directly comparable studies in the
primary care sector in GB. In 2005/2006 there were 169
hospital episodes of accidental poisoning by exposure to
pesticides in the UK, 93% of which were emergency
admissions and 70% occurred to children under the age of
15 years [5].
Table 2: Pest control chemical use at home
Pest-control chemical Number of Patients Percentage of Pesticide Users Reported more use than usual
Number %
Weed killer 131 23.9 74 56.5
Kill root/nettles etc 60 11.0 32 53.3
Kill aphids/greenfly etc 89 16.3 47 52.8
Kill wasp/fly 78 14.3 43 55.1
Kill ant/cockroach etc 80 14.6 57 71.3
Fungicidal paint 7 1.3 5 71.4
Mould/mildew treatment 48 8.8 30 62.5
Tick/flea control 98 17.9 44 44.9
Head lice treatment 17 3.1 11 64.7
Insect repellent 35 6.4 20 57.1
Other animal repellent 12 2.2 9 75.0
Rat/mouse poison 30 5.5 16 53.3
Slug/snail pellets 149 27.2 81 54.4
Creosol/cuprinol 57 10.4 42 73.7
Dry rot treatment 2 0.4 2 100.0
Kill algae/lichen/moss 15 2.7 7 46.7
Intestinal worm treatment 55 10.1 22 40.0
Other 22 4.0 15 68.2BMC Public Health 2009, 9:219 http://www.biomedcentral.com/1471-2458/9/219
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Table 3: Univariable logistic regression models for the likelihood of being categorised by the GP as having symptoms possibly related 
to pesticide exposure
Factors affecting pesticide related illness Proportion of Participants (%)
(n = 1316)
Odds Ratio
(95% Confidence Interval)
Occupational pesticide use versus no use 6 1.17 (0.62, 2.20)
Home pesticide use versus no use 41 1.83 (1.49, 2.26)
Age (one year increase) - 0.99 (0.985, 0.997)
Male versus female 42 1.0 (0.81, 1.24)
Proximity of farmland 100 m-1 km vs < 100 m 29 0.65 (0.45, 0.93)
> 1 km vs < 100 m 40 1.79 (0.55, 5.83)
Don't know vs < 100 m 2 0.59 (0.26, 1.36)
Proximity of chemical plant 100 m-1 km vs < 100 m 2 0.91 (0.19, 4.32)
> 1 km vs < 100 m 62 1.23 (0.25, 6.05)
Don't know vs < 100 m 35 0.69 (0.19, 2.49)
Proximity of landfill site 100 m-1 km vs < 100 m 3 2.92 (0.81, 10.49)
> 1 km vs < 100 m 80 1.84 (0.39, 8.68)
Don't know vs < 100 m 16 1.38 (0.30, 6.35)
Proximity of heavy traffic 100 m-1 km vs < 100 m 37 0.93 (0.66, 1.31)
> 1 km vs < 100 m 39 0.80 (0.46, 1.37)
Don't know vs < 100 m 1 0.53 (0.12, 2.23)
Proximity of railway 100 m-1 km vs < 100 m 30 0.96 (0.65, 1.43)
> 1 km vs < 100 m 58 1.41 (0.70, 2.84)
Don't know vs < 100 m 4 0.84 (0.27, 2.63)
Area of living Surburban versus urban 37 0.29 (0.08, 1.02)
Rural versus urban 39 0.29 (0.07, 1.1)
Change in use of Laundry detergent 9 1.60 (0.93, 2.76)
Change in use of Disinfectant/bleach 8 1.26 (0.81, 1.95)
Change in use of Cleaning agent 8 1.43 (0.88, 2.34)
Change in use of White spirit 9 1.60 (1.06, 2.41)
Change in use of Polish/varnish 6 1.83 (0.92, 3.66)
Change in use of Air freshener 10 1.25 (0.89, 1.77)
Change in use of Paint 11 1.74 (1.19, 2.54)
Change in use of Toiletries 7 1.85 (1.22, 2.80)
Change in use of Stain remover 4 1.36 (0.63, 2.91)
Change in use of Furniture renovator 4 1.86 (1.19, 2.93)
Change in use of Oil/grease 3 1.12 (0.49, 2.57)
Change in use of Insulation material 5 1.06 (0.64, 1.74)BMC Public Health 2009, 9:219 http://www.biomedcentral.com/1471-2458/9/219
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Other countries also monitor acute pesticide poisoning
and there has been some attempt by the World Health
Organization to provide a standardised case definition
and classification scheme with regard to exposure, health
effects and causality [9]. Underreporting of acute events
can occur in monitoring systems, as illustrated in a cross-
sectional survey Nicaragua [10]. Pesticide-related illness
as an important cause of acute morbidity among migrant
workers has also been found in multi-state standardised
occupational surveillance programs such as those led by
the US National Institute for Occupational Safety and
Health which include primary care physicians [11].
In designing our study we found few UK based statistics
on which to base sample size calculations but anticipated
that the incidence of possible pesticide-related illness
could potentially be as low as 1% (as indeed was the case,
1.6%) An early study on deaths from pesticide poisoning
in England and Wales indicated that such deaths repre-
sented 1.1% of all deaths from poisoning over 1945–
1989 [12] and at least 73% of these pesticide fatalities
were due to suicide. We originally aimed to recruit 70
practices from the GPRF giving access to approximately
420,000 patients, about 0.75% of the UK population but,
although the GPRF network consists of practices inter-
ested in participating in research, it proved difficult to
recruit them. We did, however, manage to recruit 43 Prac-
tices with over 160 GPs and nurse practitioners participat-
ing in the study.
These practices were well spread geographically through-
out GB between urban, suburban and rural areas and
between different areas of deprivation, with the average
list size per GP in the practices being 2210, varying from
under 1000 in a rural area to over 2500 in 2 city practices.
The average list size of GPs during our study period in
England and Wales was 1666 [13]. The average number of
surgeries held per week per practice, used for the pesticide
project in the participating practices, was 2.4 over the
study period. In the UK generally the average number of
surgery sessions held weekly by GPs is about 8. The study
thus included about 30% of the consulting workload of
each participating GP. Overall, of all those patients
screened, 15.5% of those not asymptomatic (6930 of
44829 patients with symptoms) had a respiratory prob-
lem (including flu-like symptoms). The same proportion
of patients was estimated to consult their GP for respira-
tory condition problems in the UK in 2002 [13]. The cor-
responding figures from our study and for the UK
respectively are: skin symptoms 12.2%, 10.9%; eye prob-
lems 2.2%, 4.5%; gastrointestinal (our study)/digestive
system (UK figures) 8.7%, 7.2%; neurological (our
study)/nervous system (UK figures) 1.8%, 3.4%.
Although in our study all participants were over 18 years
old and the UK estimates include all ages the similarity of
these figures suggests that our study closely mirrors the
general pattern of symptoms within the UK consultations.
Over 40% of those interviewed in our study had use a
household pesticide in the week before symptoms devel-
oped. Other studies have tended to ask about past use of
household pesticides over a longer period. For example, a
case-control study of childhood haematopoietic malig-
nancies in France found that about 50% of mothers of
cases had used a household pesticide during pregnancy;
use varied by type of residence and area of residence e.g.
for fathers use during pregnancy was 72%, 61% and 44%
for rural, mixed and urban areas respectively and 86%,
67% and 26% for living in a farm, house and flat respec-
tively [14]. A similar study of childhood leukaemia found
that more than half of households had used insecticides
or indoor pesticides during the first year after the birth of
the child [15]. A UK survey of a sample of parents from the
Avon Longitudinal Study of Parents and Children found
that 93% had used at least one pesticide product in the
last year with a range of frequencies [16]. For example,
33% of parents used pesticides to treat pets with a median
use of 4 times per year; other use included insecticides
(42% of parents, 1–90 applications per year, median 2.5),
slug pellets (44% of parents, 1–60 applications per year,
median 4), weed killer (27% of parents, 1–18 applica-
tions per year, median 2). A UK observational study found
that few participants read the label, that they often found
it hard to understand and that compliance with instruc-
tion was low [17].
Our study is limited in some aspects. It was felt that it
would be too impractical and costly to try and interview
in depth a random sample of patients consulting their
GPs throughout a year at a large number of practices. We
also wanted to gain some knowledge of GP diagnosing of
pesticide-related illness. The screening checklist was thus
designed to include this and to screen out patients who
were asymptomatic, consulting for on-going/chronic
health problems or whose symptoms, in the opinion of
the GP, were definitely not related to pesticide exposure.
This reduced the proportion of patients eligible for an
interview to 8%. Some of those not invited for interview
could have had a pesticide-related problem not attributed
by either the patient or GP to pesticides, leading to poten-
tial underestimation of incidence and prevalence.
At the completion of the study a follow-up questionnaire
was sent to GPs (86 GPs from 32 of the 43 practices
responded) to investigate how they decided on their clas-
sification of the likelihood of pesticide-related illness. 71
GP (83%) of the respondents classified patients to have
possibly pesticide related illness on the basis of symptoms
and/or activities before the symptoms occurred. Only one
GP reported using only a mention of pesticides to catego-BMC Public Health 2009, 9:219 http://www.biomedcentral.com/1471-2458/9/219
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rise a patient as 'possible case'. These results confirm that
very few GP specifically discussed pesticides with the
patient when categorising them as 'possible related to pes-
ticide exposure'.
A high proportion (44%) of those invited for interview
refused to participate and this did not improve after we
had received ethical approval to carry out telephone inter-
views. However, overall, 50% of those who did not refuse
were interviewed. The interview questionnaire was fairly
lengthy. It was felt important to consider total exposure to
pesticides from all sources. The interview thus attempted
to capture these data. The information on actual chemi-
cals and active ingredients of pesticides is, however, lim-
ited as it was thought that patients would either not know
this or be unable to recall it accurately. The study was thus
limited in its ability to define a definitive pesticide-related
case of ill- health. However, other systems such as the
SENSOR system in the US and the Pesticides Incident
Reporting Scheme in the UK also use some element of
self-reporting and expert judgement, particularly in defin-
ing a possible case [18,19]. In addition we did not, in this
study, follow up patients categorised as having likely or
possible pesticide-related illness with regard to treatments
or the results of this. The establishment of a definite causal
relationship from these systems, as in our study, would
thus require careful consideration.
A clear outcome from the study is that it would not be fea-
sible to implement the methods used in this study for a
wider surveillance system in GB. Screening of patients at
nearly 60,000 consultations yielded relatively few likely or
probable cases of pesticide-related symptoms. The project
also required constant monitoring, and motivation and
encouragement of the practices. This would be infeasible
as part of a routine monitoring system.
Throughout the world primary care surveillance networks
have been developed that monitor voluntarily one or
more specific illness problems on a regular or continuing
basis [20,21]. The main objective of these is on disease
surveillance, many focussing on infectious diseases
nationally or as part of international networks such as
GeoSentinel and TropNetEurope [22,23]. Primary Care
physicians may also detect sentinel cases of occupation-
ally or environmentally caused diseases. For example, a
cluster of Guillain-Barre syndrome cases was observed in
relation to aerial organophosphate insecticides [24].
In the UK, it has been shown that none of the existing GP
morbidity recording schemes routinely recorded occupa-
tion although it would be feasible to add procedures to
obtain this information [25], as it would for environmen-
tal factors. The importance of incorporating environmen-
tal health into primary care education and practice has
been recognised in other countries. In the US, the
National Strategies for Health Care Providers: Pesticides
Initiative and the national Environmental Public Health
Tracking program have been launched [26,27]. The
former aims to raise awareness among GPs and nurses of
potential exposures to pesticides. Cities like New York are
investigating how to develop their capacities to track and
link environmental public health indicators such as pesti-
cide sales and applications, housing and building infor-
mation and medical data. However, data collected for
surveillance need to be relevant and action-driven [28]. In
many studies worldwide there has been recognition of the
under-reporting of pesticide related poisoning and the
need to improve surveillance [29]. Although the preva-
lence and incidence results from our study are small these
potentially give fairly large number of patients presenting
to GPs each week with possible pesticide related illnesses,
albeit mild ones. Our study has thus shown that there is a
need to extend surveillance to include Primary Care.
Conclusion
The use of pesticides was widespread among interviewees
in the home environment and there was unsatisfactory
use of product labels and precautionary measures; storage
and disposal of pesticides was also poor. Although the
estimated annual prevalence and incidence of pesticide
related illness reported to and diagnosed in Primary Care
was small, this implies large numbers of consultations
potentially concerning pesticide exposure. The study
Table 4: Multivariable logistic regression model for the likelihood of being categorised by the GP as having symptoms possibly related 
to pesticide exposure
Factors affecting pesticide related illness Multivariable model
OR (95% CI)
Occupational pesticide use versus no use 0.99 (0.53, 1.88)
Home pesticide use versus no use 1.88 (1.51, 2.35)
Age (1 year increase) 0.99 (0.99, 1.00)
Male versus female 1.02 (0.81, 1.28)BMC Public Health 2009, 9:219 http://www.biomedcentral.com/1471-2458/9/219
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methods used here are not feasible for routine pesticide
illness monitoring system. However, there is a need to
incorporate environmental health into Primary Care edu-
cation and practice.
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